Hajime Sasagawa
Yokohama, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Reassessment of T1a cutoff for kidney cancer in the robotic era.
Journal: Journal of robotic surgery
Published: August 03, 2025
Revisiting the impact of BRCA1 pathogenic variants on the aggressiveness of prostate cancer.
Journal: JNCI cancer spectrum
Published: August 03, 2025
BRCA1 and BRCA2 pathogenic variants increase the risk of four less common cancer types.
Journal: ESMO open
Published: April 09, 2025
Comparative transcriptome atlas as an assistive modality for complex classification of rare kidney cancers.
Journal: Nature communications
Published: January 30, 2025
The lymphocyte-to-monocyte ratio as a significant inflammatory marker associated with survival of patients with metastatic renal cell carcinoma treated using nivolumab plus ipilimumab therapy.
Journal: International journal of clinical oncology
Published: February 03, 2024
The Current Trend of Radiation Therapy for Patients with Localized Prostate Cancer.
Journal: Current oncology (Toronto, Ont.)
Published: June 23, 2023
Real clinical outcomes of nivolumab plus ipilimumab for renal cell carcinoma in patients over 75 years old.
Journal: International journal of clinical oncology
Published: June 20, 2023
Androgen deprivation therapy caused a drastic proliferation of B-cell lymphoma with IgG4-related disease in patients with prostate cancer: a case report.
Journal: Journal of cancer research and clinical oncology
Published: June 18, 2023
Severe Immune-Related Adverse Events in Patients Treated with Nivolumab for Metastatic Renal Cell Carcinoma Are Associated with PDCD1 Polymorphism.
Journal: Genes
Published: May 18, 2022
Successful Re-Administration of Nivolumab in Patient with Metastatic Renal Cell Carcinoma : A Case Report
Journal: Hinyokika kiyo. Acta urologica Japonica
Published: January 07, 2022
Showing 1-11 of 11
Last Updated: 09/26/2026